Letter to the editor: RECAM for the diagnosis of DILI—Is it time to incorporate additional pharmacological criteria?
Emanuel Raschi, Paolo Caraceni – 16 February 2022
Health Disparities in Screening, Diagnosis, and Treatment of Hepatocellular Carcinoma
Averill Guo, Sydney Pomenti, Julia Wattacheril – 15 February 2022
At Diagnosis of Hepatocellular Carcinoma, African Americans With Hepatitis C Have Better Liver Function Than Other Patients
Adam C. Winters, Julie C. Sung, Brooke Wyatt, Deeva Berera, Thomas D. Schiano, Myron E. Schwartz, Ponni V. Perumalswami, Andrea D. Branch – 15 February 2022
Table of contents
13 February 2022
Instructions to Authors
13 February 2022
Cover Image
13 February 2022
Single MHC‐I Expression Promotes Virus‐Induced Liver Immunopathology
Haifeng C. Xu, Jun Huang, Aleksandra A. Pandyra, Piyush Pandey, Ruifeng Wang, Zeli Zhang, Yuan Zhuang, Christoph G.W. Gertzen, Carsten Münk, Diran Herebian, Arndt Borkhardt, Mike Recher, Holger Gohlke, Irene Esposito, Martin Oberbarnscheidt, Dieter Häussinger, Karl S. Lang, Philipp A.
Masthead
13 February 2022
Seeking Editor for Clinical Liver Disease
13 February 2022
Hepatology Highlights
13 February 2022